Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Uncover the crypto exchanges that offer the best user experience. Choose platforms that prioritize your trading comfort and efficiency.
5,429 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Rayse introduces RAE, a conversational AI engine that lets agents log work and guide client journeys via voice or tex...
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
Three stocks mispriced right could offer substantial upside for patient investors. This article breaks down why these...
As advertisers shift to privacy-first strategies, Viant Technology (DSP) 2025 presents both opportunities and risks. ...
Markets swing, but smart investors seek durable growth. This article highlights three names with a credible path to m...
Investors are buzzing about XPeng as xpeng stock winning this week suggests growth catalysts could unfold. This guide...
Bank of America projects a future where humanoid robots outnumber cars by 2060, with two-thirds living in households....
Two frontier AI firms are tipped for 2026 IPOs, with lofty valuations and aggressive monetization bets, as markets we...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
As Microsoft trades off recently, savvy investors look for steady leaders among mega-cap stocks after microsoft's pul...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...